News

Jun 24th, 2022

Gynuity Health Projects Strongly Condemns the Supreme Court’s Decision to Withdraw Federal Protection for Abortion in the U.S.

May 17th, 2022

Newsletter: Vol. 6, No. 1, May 2022

May 10th, 2022

Gynuity Announces Collaboration with Academic Institutions to Understand the Feasibility of Introducing a New Screening Tool for Preeclampsia in Healthcare Facilities in Ethiopia and Uganda

Apr 12th, 2022

In the News. TIME: Republican States Crack Down on Access to Abortion Pills as Supreme Court Decision Looms

Mar 31st, 2022

Study Shows that Screening for Medication Abortion Using Medical History Alone is Effective and Safe

Dec 17th, 2021

Gynuity Celebrates Decision by the U.S. Food and Drug Administration to Loosen Regulations on Mifepristone

Nov 30th, 2021

Newsletter: Vol. 5, No. 4, November 2021

Nov 24th, 2021

Gynuity Health Projects Releases its 2020 Annual Report

Oct 22nd, 2021

Gynuity President Presents Alongside Leading Global Experts on Abortion at the FIGO World Congress 2021

Oct 14th, 2021

Launch of a New Website on Period Pills

Sep 28th, 2021

Newsletter: Vol. 5, No. 3, September 2021

Sep 23rd, 2021

Gynuity’s TelAbortion Study Will Stop Enrolling at the End of this Month

Sep 9th, 2021

Mexico: Supreme Court Declares Criminal Penalties for Abortion Unconstitutional / México: La Suprema Corte Declara Inconstitucionales Sanciones Penales por Aborto

May 3rd, 2021

Newsletter: Vol. 5, No. 2, May 2021

Apr 13th, 2021

Gynuity’s Research is Primary Source Cited in the U.S. Food and Drug Administration’s Decision to Suspend In-Person Mifepristone Dispensing Requirement

Mar 29th, 2021

Expansion of a Direct-to-Patient Telemedicine Abortion Service in the United States and Experience during the COVID-19 Pandemic

Jan 26th, 2021

Feasibility of Multilevel Pregnancy Tests for Telemedicine Abortion Service Follow-up: A Pilot Study

Jan 22nd, 2021

Newsletter: Vol. 5, No. 1, January 2021

Jan 12th, 2021

The Safety and Feasibility of a Family First Aid Approach for the Management of Postpartum Hemorrhage in Home Births: A Pre‑Post Intervention Study in Rural Pakistan

Dec 3rd, 2020

In the News. New York Times: Why Some Women Might Want 'Missed-Period Pills'

Nov 24th, 2020

Newsletter: Vol. 4, No. 5, November 2020

Oct 30th, 2020

Exploring Potential Interest in Missed Period Pills in two US States

Aug 31st, 2020

Newsletter: Vol. 4, No. 4, August 2020

Jul 22nd, 2020

A Repeat Dose of Misoprostol 800mcg Following Mifepristone for Outpatient Medical Abortion at 64-70 and 71-77 Days of Gestation: A Retrospective Chart Review

Jun 22nd, 2020

Newsletter: Vol. 4, No. 3, June 2020